GlassScriptPhysician profile
Cesar Arvid Rivera
NPI 1801326855
$7,604.07
in general payments reported to CMS, 2019-2025
15 companies · $3,529 in 2025
The $3,529 reported for 2025 was more than what 95% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.00 · 2020: $11.80 · 2021: $464 · 2022: $1,593 · 2023: $1,399 · 2024: $592 · 2025: $3,529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,138 · Food and Beverage: $2,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,138.27 |
| Food and Beverage | $2,381.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $3,806.09 | 2023-2025 | Biohorizons, Biohorizons Dental Implants, Biohorizons Dental Prosthetics |
| Depuy Synthes Sales INC. | $934.35 | 2021-2023 | Matrixmandible, Trumatch |
| Axogen | $920.80 | 2022-2023 | Avance Nerve Graft |
| Kls-Martin L.P. | $780.72 | 2021-2023 | |
| Stryker Corporation | $705.83 | 2021-2025 | Na, Vsp System, Vsp Cranial, Smartlock |
| Zimmer Biomet Holdings, INC. | $143.88 | 2022 | |
| Align Technology, INC. | $106.36 | 2024 | Invisalign |
| Novartis Pharmaceuticals Corporation | $85.59 | 2024-2025 | |
| Inspire Medical Systems, INC. | $28.58 | 2023 | Inspire |
| Checkpoint Surgical, INC | $23.38 | 2022 | |
| Integra Lifesciences Corporation | $18.58 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Orapharma, A Division of Bausch Health US, LLC | $15.00 | 2019 | |
| Kci USA, INC. | $11.80 | 2020 | |
| Acacia Pharma INC | $11.71 | 2021 | |
| Merck Sharp & Dohme LLC | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cesar Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.